Structure-Based Drug Discovery Consulting
Rigorous structural analysis to inform target, selectivity, and lead advancement decisions
THE CHALLENGE
Early drug discovery advances through decisions made under mechanistic uncertainty. Target engagement, selectivity, druggability, and off-target risk must be evaluated before significant experimental resources are committed.
​
Yet computational analysis is often fragmented or method-driven. Without integrated structural evaluation, uncertainty persists and propagates downstream, increasing the probability of costly failure.
OUR SOLUTION
Discovera provides structure-based CADD consulting to resolve mechanistic uncertainty before experimental commintment.
Compounds and targets are evaluated through rigorous structural modeling and comparative interaction analysis, translating findings into clear conclusions.​
Each engagement is anchored to the R&D decision it must inform, with critically interpreted results delivered in a technically grounded report to support confident advancement or redesign.
​
What we do
TARGET ENGAGEMENT &
DRUGGABILITY ASSESSMENT
Evaluation of binding site properties, pocket geometry, and interaction hotspots to determine wheather robust ligand engagement is chemically and physically plausible, assessing target tractability before experimental commitment.
SELECTIVITY & OFF-TARGET RISK
ANALYSIS
Comparative binding analysis across the intended target. interaction fingerprints and binding mode consistency are examined to anticipate selectivity
risks and structural liabilities.
HIT PRIORITIZATION & STRUCTURE-GUIDED OPTIMIZATION
Candidate compounds are evaluated within the defined target framework to determine which chemotypes best satisfy key interaction requirements and steric constraints. Structural differences are translated into priorities and concrete modification hypotheses for subsequent design cycles.
How it works
1
SCOPE & BRIEF
The scientific and strategic question is clarified upfront. Scope, assumptions, and timeline are defined to ensure the analysis addresses a specific decision point.
2
COMPUTE & ANALYZE
The right computational strategy is selected based on the question. Relevant computational models and approaches are applied and results are critically evaluated for internal consistency and mechanistic plausibility.
3
REPORT & ADVISE
Findings are integrated into a full technical report.
Conclusions are stated clearly, limitations are identified, and concrete implications for advancement, prioritization, or structural modification are defined.
Why Discovera
Decision-Focused Engagement
Every project is anchored to a defined scientific
question and the specific R&D decision it must inform.
Reports are structured, documented, and reproducible to support internal governance and potential IND-facing documentation
Regulatory-Grade Reporting
Rigorous Structural Evaluation
Conclusions are derived from direct analysis of ligand-target interactions and comparative structural assessment, with scoring metrics interpreted critically rather than accepted at face value.
Analytical Integrity
Findings are interpreted objectively, with assumptions and methodological limits stated explicitly to prevent overinterpretation.
Defined Scope and Predictable Delivery
Objectives, timelines, and deliverables are agreed upfront to ensure focused and transparent collaboration.